Adult Stem Cells
Adult Stem Cells

Adult Stem Cell Clinical Trial for Patients with Chronic Obstructive Pulmonary Disease (COPD)

CLINICAL TRIAL

Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease (COPD)

PURPOSE

The intent of this clinical study is to answer the questions: 1) Is the proposed treatment safe and 2) Is treatment effective in improving the health of patients with human Chronic Obstructive Pulmonary Disease.

OFFICIAL TITLE

An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Intra-venous Implantation of Autologous Adipose-Derived Stem Cells in Patients With Chronic Obstructive Pulmonary Disease (Clinical Trial Identifier: NCT01559051)

STUDY DESIGN & DATES

Phase I & II, Non-Randomized
Study Start Date: May 2011
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: Dec 2014 (Final data collection date for primary outcome measure)

CONTACTS

Kristin Comella
Phone: 813 390 9874
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

LOCATIONS

Mexico:
Hospital Angeles

Tijuana, Baja California, Mexico, 22010

Contact: Jesus Perez ( This email address is being protected from spambots. You need JavaScript enabled to view it. )

INVESTIGATORS

Principal Investigator: Ruben Corral, MD

ELIGIBILITY: INCLUSION CRITERIA

A prior diagnosis of moderate or severe COPD

GOLD III and IV

Age between 25 and 80 years

Up to date on all age and gender appropriate cancer screening per American Cancer Society

ELIGIBILITY: EXCLUSION CRITERIA

Females who are pregnant or nursing or females of childbearing potential who are unwilling to maintain contraceptive therapy for the duration of the study

Life expectancy < 6 months due to concomitant illnesses

Exposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study

Active infectious disease patients known to have tested positive; will have an expert consulted as to patient eligibility based on the patient's infectious status

Any illness which, in the Investigator's judgment, will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results

Patients on chronic immunosuppressive transplant therapy

Known drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or who in the opinion of the investigator are not suitable to participate

Severe asthma that would contraindicate surgery

History of cancer (other than non-melanoma skin cancer or in-situ cervical cancer) in the last five years

Unwilling and/or not able to give written informed consent

CLICK FOR FULL TRIAL ENTRY on CLINICALTRIAL.GOV

All information is © 2014 by the Cell Therapy Foundation
Adult Stem Cells
This email address is being protected from spambots. You need JavaScript enabled to view it.

* Designates sites with available clinical trials.